openPR Logo
Press release

Open-Angle Glaucoma Market to Witness Growth by 2032, Estimates DelveInsight

02-28-2023 06:36 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Open-Angle Glaucoma Market to Witness Growth by 2032, Estimates

DelveInsight's "Open-Angle Glaucoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Open-Angle Glaucoma, historical and forecasted epidemiology as well as the Open-Angle Glaucoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Open-Angle Glaucoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Open-Angle Glaucoma market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Open-Angle Glaucoma treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Open-Angle Glaucoma market.

Request for a Free Sample Report @ https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma: An Overview

This is the most common form of glaucoma. The drainage angle formed by the iris and cornea remains open. But other parts of the drainage system don't drain properly. This may lead to a slow, gradual increase in eye pressure.

Learn more about Open-Angle Glaucoma, treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Market

The Open-Angle Glaucoma market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Open-Angle Glaucoma market trends by analyzing the impact of current Open-Angle Glaucoma therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Open-Angle Glaucoma market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Open-Angle Glaucoma market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Open-Angle Glaucoma market in 7MM is expected to witness a major change in the study period 2019-2032.

Request a sample and discover more about the report offerings at:
https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Epidemiology

The Open-Angle Glaucoma epidemiology section provides insights into the historical and current Open-Angle Glaucoma patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Open-Angle Glaucoma market report also provides the diagnosed patient pool, trends, and assumptions.

Explore more about Open-Angle Glaucoma Epidemiology at: https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Drugs Uptake

This section focuses on the uptake rate of the potential Open-Angle Glaucoma drugs recently launched in the Open-Angle Glaucoma market or expected to be launched in 2019-2032. The analysis covers the Open-Angle Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug.

Open-Angle Glaucoma Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Open-Angle Glaucoma market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Open-Angle Glaucoma Pipeline Development Activities

The Open-Angle Glaucoma report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Open-Angle Glaucoma key players involved in developing targeted therapeutics.

Request for a sample report to understand more about the Open-Angle Glaucoma pipeline development activities at: https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Therapeutics Assessment

Major key companies are working proactively in the Open-Angle Glaucoma Therapeutics market to develop novel therapies which will drive the Open-Angle Glaucoma treatment markets in the upcoming years.

Learn more about the emerging therapies & key companies at: https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Open-Angle Glaucoma Report Key Insights

1. Open-Angle Glaucoma Patient Population
2. Open-Angle Glaucoma Market Size and Trends
3. Key Cross Competition in the Open-Angle Glaucoma Market
4. Open-Angle Glaucoma Market Dynamics (Key Drivers and Barriers)
5. Open-Angle Glaucoma Market Opportunities
6. Open-Angle Glaucoma Therapeutic Approaches
7. Open-Angle Glaucoma Pipeline Analysis
8. Open-Angle Glaucoma Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Open-Angle Glaucoma Market

Table of Contents

1. Key Insights
2. Executive Summary
3. Open-Angle Glaucoma Competitive Intelligence Analysis
4. Open-Angle Glaucoma Market Overview at a Glance
5. Open-Angle Glaucoma Disease Background and Overview
6. Open-Angle Glaucoma Patient Journey
7. Open-Angle Glaucoma Epidemiology and Patient Population
8. Open-Angle Glaucoma Treatment Algorithm, Current Treatment, and Medical Practices
9. Open-Angle Glaucoma Unmet Needs
10. Key Endpoints of Open-Angle Glaucoma Treatment
11. Open-Angle Glaucoma Marketed Products
12. Open-Angle Glaucoma Emerging Therapies
13. Open-Angle Glaucoma Seven Major Market Analysis
14. Attribute Analysis
15. Open-Angle Glaucoma Market Outlook (7 major markets)
16. Open-Angle Glaucoma Access and Reimbursement Overview
17. KOL Views on the Open-Angle Glaucoma Market
18. Open-Angle Glaucoma Market Drivers
19. Open-Angle Glaucoma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Open-Angle Glaucoma Market report here: https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us:

Kritika Rehani
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Open-Angle Glaucoma Market to Witness Growth by 2032, Estimates DelveInsight here

News-ID: 2951450 • Views:

More Releases from DelveInsight Business Research

Gastric Cancer Market to Exceed USD 700 Million in HER2+ Segment by 2034 Across 7MM, Backed by 211,550 Annual Cases and 15+ Key Therapies | DelveInsight
Gastric Cancer Market to Exceed USD 700 Million in HER2+ Segment by 2034 Across …
Gastric cancer is the fifth most common malignancy worldwide, with incidence varying by region and highest rates reported in Eastern Asia and Eastern Europe. Japan records the highest burden among the 7MM, with about 129,500 cases in 2024. Many patients, particularly in Western countries, are diagnosed at advanced (Stage IV) stages, while Japan detects more cases early (Stage I). In the US, around 35% present with metastatic disease at diagnosis,
Myelofibrosis Market to Double by 2034, Surpassing USD 5.6 Billion Across 7MM with 9% CAGR Growth, states DelveInsight
Myelofibrosis Market to Double by 2034, Surpassing USD 5.6 Billion Across 7MM wi …
The Myelofibrosis market across the seven major markets (7MM) is anticipated to experience significant growth, rising from approximately USD 2,602 million in 2025 to nearly USD 5,638 million by 2034, reflecting a compound annual growth rate (CAGR) of about 9% during the forecast period. In 2024, the market was valued at around USD 2.2 billion, with the United States leading at nearly USD 1.7 billion, far surpassing the EU4, the United
Triple-Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Pipeline Assets, According to DelveInsight
Triple-Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Pipelin …
An expanding portfolio of novel therapies for triple-negative breast cancer (TNBC) including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) is anticipated to significantly influence market expansion and transform the TNBC treatment landscape. DelveInsight's Triple Negative Breast Cancer Pipeline Insight report offers an extensive evaluation of more than 165 companies and over 170 therapeutic candidates advancing through the TNBC pipeline. The
Asthma Market to Witness Steady Growth Through 2034 Driven by Novel Biologics and Triple-Combination Therapies | DelveInsight
Asthma Market to Witness Steady Growth Through 2034 Driven by Novel Biologics an …
DelveInsight's latest Asthma Market Insights, Epidemiology, and Market Forecast - 2034 report provides an in-depth evaluation of current treatment practices, emerging asthma drugs, market share of individual therapies, and forecasted market trends across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The asthma market is expected to experience sustained growth over the next decade, supported by the launch of

All 5 Releases


More Releases for Glaucoma

Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The glaucoma surgery devices
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028. Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926 This latest report researches the industry structure, sales, revenue,
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and